Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 37.87

+33.8%

Nov 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: mopgcw	7/20/2007 4:02:48 AM
	Read Replies (1) of 566

Rigel Pharmaceuticals Rated New `Outperform' at Credit Suisse 2007-07-19 09:26 (New York) Princeton, New Jersey, July 19 (Bloomberg Data) -- Rigel Pharmaceuticals Inc. (RIGL US) was rated new ``outperform'' in new coverage by analyst Michael Aberman at Credit Suisse. The 12-month price target is $12.00 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next